e-learning
resources
Stockholm 2007
Wednesday 19.09.2007
Mouse models of allergic airway inflammation
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Nerve growth factor: increased airway responsiveness and exhaled nitric oxide
via
a histamine-dependent mechanism
L. Bennedich Kahn, L. E. Gustafsson, C. Olgart Höglund (Stockholm, Sweden)
Source:
Annual Congress 2007 - Mouse models of allergic airway inflammation
Session:
Mouse models of allergic airway inflammation
Session type:
Electronic Poster Discussion
Number:
4338
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
L. Bennedich Kahn, L. E. Gustafsson, C. Olgart Höglund (Stockholm, Sweden). Nerve growth factor: increased airway responsiveness and exhaled nitric oxide
via
a histamine-dependent mechanism. Eur Respir J 2007; 30: Suppl. 51, 4338
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Late Breaking Abstract - Implications of treatable traits and treatment choices on exacerbation risk in moderate-severe asthma
Management of Severe Asthma in Pediatric Patients by an Interdisciplinary Team in a Public Hospital Setting.
Respiratory sequelae of preterm birth across the life span
Related content which might interest you:
Mechanisms of decrease in fractional exhaled nitric oxide during acute bronchoconstriction
Source: Annual Congress 2010 - Asthma: breath biomarkers and asthma control
Year: 2010
Exhaled nitric oxide during infancy as a risk factor for asthma and airway hyperreactivity
Source: Eur Respir J 2015; 45: 98-106
Year: 2015
Biomarkers of human asthma; the effect of inhaled AMP on exhaled nitric oxide and circulating VEGF levels
Source: Eur Respir J 2005; 26: Suppl. 49, 229s
Year: 2005
Salbutamol temporarily increases the bronchial production of nitric oxide
Source: Eur Respir J 2007; 30: Suppl. 51, 63s
Year: 2007
Buffering airway acid decreases exhaled nitric oxide levels in humans
Source: Eur Respir J 2004; 24: Suppl. 48, 578s
Year: 2004
Airway and systemic nitric oxide pathway in COPD
Source: International Congress 2019 – FeNO in airway diseases and asthma-COPD overlap identification
Year: 2019
Characteristics of exercise induced bronchoconstriction in asthmatic children according to exhaled nitric oxide
Source: International Congress 2016 – What's new in paediatric respiratory physiology?
Year: 2016
Reduced bronchial nitric oxide flux but unchanged alveolar nitric oxide concentration after exposure to hyperbaric hyperoxia
Source: Annual Congress 2010 - New diagnostic approaches in respiratory function
Year: 2010
Methacholine hyperresponsiveness was related to nitric oxide regulation in growth restricted preterm born children
Source: International Congress 2016 – Insights into the pathophysiology of childhood lung disease
Year: 2016
Exercise induced contraction of conducting airways in asthmatic children is significantly related to an increased exhaled nitric oxide
Source: Annual Congress 2009 - Airway inflammation and asthma control
Year: 2009
Nitric oxide is a poor bronchodilator but reduces release of leukotrienes in the peripheral airways
Source: Eur Respir J 2005; 26: Suppl. 49, 128s
Year: 2005
Bronchial and alveolar components of exhaled nitric oxide and their relationship
Source: Eur Respir J 2012; 39: 1258-1261
Year: 2012
Early rise in exhaled nitric oxide and mast cell activation in repeated low-dose allergen challenge
Source: Eur Respir J 2006; 27: 1152-1159
Year: 2006
Smoking decreases bronchial nitric oxide output
Source: Eur Respir J 2005; 26: Suppl. 49, 152s
Year: 2005
Nasal nitric oxide
Source: Eur Respir Monogr 2010; 49: 71-81
Year: 2010
Lactose-β-sitosterol inhibits ovalbumin-induced asthmatic inflammation with no influence on nitric oxide pathway
Source: Annual Congress 2010 - Animal models of asthma and lung inflammation
Year: 2010
Increased nitric oxide production by neutrophils in bronchial asthma
Source: Eur Respir J 2001; 17: 868-871
Year: 2001
Role of the nitric oxide in the lung function and airway hyperreactivity in silicotic mice
Source: Annual Congress 2013 –The multiple faces of stress in lung injury
Year: 2013
Levels of asthma control and exhaled nitric oxide
Source: Annual Congress 2009 - Airway inflammation and asthma control
Year: 2009
Differential assessment of airway inflammation and anti-inflammatory treatment in asthma by measurements of exhaled nitric oxide (NO) derived from peripheral
versus
central airways
Source: Eur Respir J 2003; 22: Suppl. 45, 449s
Year: 2003
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept